Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net income (loss) $ (16,987) $ 53,448
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 135,563 127,843
Loss on extinguishment of debt 27,700 0
Software impairment charge 29,839 0
Deferred income tax expense (benefit) (5,006) 8,629
Impairment of equity method investment 12,593 0
Share-based compensation expense 8,074 6,124
Other noncash income and expense items 14,146 7,206
Change in operating assets and liabilities 20,588 16,967
Net cash provided by operating activities 226,510 220,217
Cash flows from investing activities:    
Purchases of property and equipment (134,562) (124,871)
Grant proceeds 14,007 1,136
Purchase of businesses, net of cash received (12,736) (1,670)
Proceeds from sale of investment 7,551 0
Purchases of other assets and intangible assets (7,191) (7,735)
Note receivable issued to an equity method investee (3,000) 0
Restricted cash 49 5,871
Purchase of investments 0 (21,409)
Other (4,760) 49
Net cash used for investing activities (140,642) (148,629)
Cash flows from financing activities:    
Repayment of debt and capital lease obligations (492,068) (97,388)
Issuance of 2025 Notes 445,973 0
Borrowing on Amended Senior Credit Facility 295,000 55,000
Purchase of noncontrolling interests (282,505) 0
Issuance of Searchlight note payable and derivative stock appreciation rights 75,000 0
Purchase of treasury stock to be retired (44,324) (1,972)
Payment of bond call premium (20,244) 0
Payment of debt issuance costs (13,979) 0
Distribution to non-controlling interest (4,932) (37,500)
Proceeds from stock option exercises 295 344
Borrowing on other long-term debt 203 421
Net cash (used for) provided by financing activities (41,581) (81,095)
Net increase (decrease) in cash and cash equivalents 44,287 (9,507)
Cash and cash equivalents at beginning of period 15,402 44,971
Cash and cash equivalents at end of period $ 59,689 $ 35,464